EMAN RESEARCH PUBLISHING | Journal | <p>Targeting inducible Nitric Oxide Synthase (iNOS) in the prevention of vascular damage and cardiac inflammation in CVD</p>
Inflammation Cancer Angiogenesis Biology and Therapeutics | Impact 0.1 (CiteScore) | Online ISSN  2207-872X
REVIEWS   (Open Access)

Targeting inducible Nitric Oxide Synthase (iNOS) in the prevention of vascular damage and cardiac inflammation in CVD

Nafees Uddin Chowdhurya, Abida Tishab, Juthika Sarkerb, Pulak Dev Nathb, Nowshin Ahmedb, Shahanshah Abdullahb, Tasdik Farooqb, Waich Mahmudb, Md. Mohabbulla Mohibb,c, Md. Abu Taher Sagorb

+ Author Affiliations

Journal of Angiotherapy 2(1) 067-077 https://doi.org/10.25163/angiotherapy.1200032116160818

Submitted: 01 June 2018  Revised: 15 August 2018  Published: 16 August 2018 

The molecular mechanism of iNOS that leads to CVD is comprehensively summarized in this review so as to aid in drug discovery strategies for the treatment of CVD.


Vascular damage and subsequent cardiac failure due to immune cytokines is steadily increasing the morbidity of cardiovascular diseases (CVD), making them the leading cause of death globally. Nevertheless, improper diagnosis is an important hurdle in case management. Free radicals are one of major factors in producing vascular abnormalities in CVD. Additionally, some other factors such as high blood pressure, myocardial injuries, vascular damage, ventricular hypertrophy, cardiac fibrosis and myocardial necrosis are also the results of free radical-mediated abnormal cardiac activity/function. Of note, Nitric Oxide Synthase (iNOS) is produced in the body at an elevated rate in the presence of free radicals which has been shown to lead to cardiac issues. Furthermore, iNOS is also increased due to cytoplasmic stress, faulty DNA replication and membrane potential impairment. Moreover, abnormal cardiac rhythm has also been reported to be linked to the presence of iNOS. iNOS can also lead to abnormal cardiac function through inhibition of mitochondrial activity and production of pro-inflammatory cytokines. The molecular mechanism of iNOS that leads to CVD is comprehensively summarized in this review so as to aid in drug discovery strategies for the treatment of CVD.

Key words: iNOS, Immunity, Inflammation, Hypertension, vascular damage


Abdelsalam, R. M., & Safar, M. M. (2015). Neuroprotective effects of vildagliptin in rat rotenone Parkinson's disease model: role of RAGE-NFκB and Nrf2-antioxidant signaling pathways. Journal of neurochemistry, 133(5), 700-707.

Abu Taher Sagor, M. Angiotensin-II, a potent peptide, participates in the development of hepatic dysfunctions. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry, 16, 1-17.

Abu Taher Sagor, M., Mahmud Reza, H., Tabassum, N., Sikder, B., Ulla, A., Subhan, N., . . . Ashraful Alam, M. (2016). Supplementation of rosemary leaves (Rosmarinus officinalis) powder attenuates oxidative stress, inflammation and fibrosis in carbon tetrachloride (CCl4) treated rats. Current Nutrition & Food Science, 12(4), 288-295.

Aktan, F. (2004). iNOS-mediated nitric oxide production and its regulation. Life sciences, 75(6), 639-653.

Alam, M. A., Chowdhury, M. R. H., Jain, P., Sagor, M. A. T., & Reza, H. M. (2015). DPP-4 inhibitor sitagliptin prevents inflammation and oxidative stress of heart and kidney in two kidney and one clip (2K1C) rats. Diabetology & metabolic syndrome, 7(1), 107.
PMid:26609328 PMCid:PMC4658771

Alderton, W. K., Cooper, C. E., & Knowles, R. G. (2001). Nitric oxide synthases: structure, function and inhibition. Biochemical Journal, 357(3), 593-615.
PMid:11463332 PMCid:PMC1221991

Ali, A., Kaur, G., Hamid, H., Abdullah, T., Ali, M., Niwa, M., & Alam, M. (2003). Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. Journal of Asian natural products research, 5(2), 137-142.

Anavi, S., Eisenberg-Bord, M., Hahn-Obercyger, M., Genin, O., Pines, M., & Tirosh, O. (2015). The role of iNOS in cholesterol-induced liver fibrosis. Laboratory investigation, 95(8), 914.

Asano, K., Chee, C., Gaston, B., Lilly, C. M., Gerard, C., Drazen, J. M., & Stamler, J. S. (1994). Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proceedings of the National Academy of Sciences, 91(21), 10089-10093.

AT Sagor, M., M Mohib, M., S Azam, M., Rahman, A., T Tanmoy, F., K Chowdhury, W., . . . A Alam, M. (2016). Angiotensin-II, a Potent Peptide, Participates in the Development of Hepatic Dysfunctions. Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry-Immunology, Endocrine and Metabolic Agents), 16(3), 161-177.

Bae, U.-J., Song, M.-Y., Jang, H.-Y., Lim, J. M., Lee, S. Y., Ryu, J.-H., & Park, B.-H. (2015). Emodin isolated from Rheum palmatum prevents cytokine-induced β-cell damage and the development of type 1 diabetes. Journal of Functional Foods, 16, 9-19.

Ballantyne, C. M., & Nambi, V. (2005). Markers of inflammation and their clinical significance. Atherosclerosis Supplements, 6(2), 21-29.

Baynosa, R. C., Naig, A. L., Murphy, P. S., Fang, X. H., Stephenson, L. L., Khiabani, K. T., . . . Zamboni, W. A. (2013). The effect of hyperbaric oxygen on nitric oxide synthase activity and expression in ischemia-reperfusion injury. journal of surgical research, 183(1), 355-361.

Cabrera-Fuentes, H. A., Ruiz-Meana, M., Simsekyilmaz, S., Kostin, S., Inserte, J., Saffarzadeh, M., . . . Barreto, G. (2014). RNase1 prevents the damaging interplay between extracellular RNA and tumour necrosis factor-α in cardiac ischaemia/reperfusion injury. Thrombosis & Haemostasis, 112(6), 1110-1119.

Chan, E. D., Chan, J., & Schluger, N. W. (2001). What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. American journal of respiratory cell and molecular biology, 25(5), 606-612.

Charles, I. G., Palmer, R., Hickery, M. S., Bayliss, M. T., Chubb, A. P., Hall, V. S., . . . Moncada, S. (1993). Cloning, characterization, and expression of a cDNA encoding an inducible nitric oxide synthase from the human chondrocyte. Proceedings of the National Academy of Sciences, 90(23), 11419-11423.

Chen, B.-Y., Lin, D. P.-C., Wu, C.-Y., Teng, M.-C., Sun, C.-Y., Tsai, Y.-T., . . . Chang, H.-H. (2011). Dietary zerumbone prevents mouse cornea from UVB-induced photokeratitis through inhibition of NF-κB, iNOS, and TNF-α expression and reduction of MDA accumulation.

Cho, H. J., Xie, Q., Calaycay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., & Nathan, C. (1992). Calmodulin is a subunit of nitric oxide synthase from macrophages. Journal of experimental medicine, 176(2), 599-604.

Chow, B. S. M., Chew, E. G. Y., Zhao, C., Bathgate, R. A., Hewitson, T. D., & Samuel, C. S. (2012). Relaxin signals through a RXFP1-pERK-nNOS-NO-cGMP-dependent pathway to up-regulate matrix metalloproteinases: the additional involvement of iNOS. PloS one, 7(8), e42714.
PMid:22936987 PMCid:PMC3425563

Chowdhury, N. U., Farooq, T., Abdullah, S., Mahadi, A. S., Hasan, M. M., Paran, T. Z., . . . Alam, M. A. (2016). Matrix Metalloproteinases (MMP), a Major Responsible Downstream Signaling Molecule for Cellular Damage-A Review. Molecular Enzymology and Drug Targets.

Costa, M. A., Elesgaray, R., Caniffi, C., Fellet, A., Mac Laughlin, M., & Arranz, C. (2010). Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats. American Journal of Physiology-Heart and Circulatory Physiology, 298(3), H778-H786.

Crump, C., Sundquist, J., Winkleby, M. A., & Sundquist, K. (2017). Interactive effects of obesity and physical fitness on risk of ischemic heart disease. International journal of obesity (2005), 41(2), 255.
PMid:27867205 PMCid:PMC5296285

Csont, T., Viappiani, S., Sawicka, J., Slee, S., Altarejos, J. Y., Batinic-Haberle, I., & Schulz, R. (2005). The involvement of superoxide and iNOS-derived NO in cardiac dysfunction induced by pro-inflammatory cytokines. Journal of molecular and cellular cardiology, 39(5), 833-840.

Daff, S., Sagami, I., & Shimizu, T. (1999). The 42-amino acid insert in the FMN domain of neuronal nitric-oxide synthase exerts control over Ca2+/calmodulin-dependent electron transfer. Journal of Biological Chemistry, 274(43), 30589-30595.

Das, A., Xi, L., & Kukreja, R. C. (2005). Phosphodiesterase-5 inhibitor sildenafil preconditions adult cardiac myocytes against necrosis and apoptosis Essential role of nitric oxide signaling. Journal of Biological Chemistry, 280(13), 12944-12955.

Das, S., Alagappan, V. K., Bagchi, D., Sharma, H. S., Maulik, N., & Das, D. K. (2005). Coordinated induction of iNOS–VEGF–KDR–eNOS after resveratrol consumption: A potential mechanism for resveratrol preconditioning of the heart. Vascular pharmacology, 42(5), 281-289.

Depre, C., Havaux, X., Renkin, J., Vanoverschelde, J. L. J., & Wijns, W. (1999). Expression of inducible nitric oxide synthase in human coronary atherosclerotic plaque. Cardiovascular research, 41(2), 465-472.

Depré, C., Wijns, W., Robert, A. M., Renkin, J. P., & Havaux, X. (1997). Pathology of unstable plaque: correlation with the clinical severity of acute coronary syndromes. Journal of the American College of Cardiology, 30(3), 694-702.

Dhillon, S. S., Mastropaolo, L. A., Murchie, R., Griffiths, C., Thöni, C., Elkadri, A., . . . Guo, C. (2014). Higher activity of the inducible nitric oxide synthase contributes to very early onset inflammatory bowel disease. Clinical and translational gastroenterology, 5(1), e46.
PMid:24430113 PMCid:PMC3912315

Dias, A. S., Porawski, M., Alonso, M., Marroni, N., Collado, P. S., & González-Gallego, J. (2005). Quercetin decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic rats. The Journal of nutrition, 135(10), 2299-2304.

Dwivedi, S. (2007). Terminalia arjuna Wight & Arn.—a useful drug for cardiovascular disorders. Journal of Ethnopharmacology, 114(2), 114-129.

Eckel, R. H. (1997). Obesity and heart disease. Circulation, 96(9), 3248-3250.

Eggers, K. M., Oldgren, J., Nordenskjöld, A., & Lindahl, B. (2004). Diagnostic value of serial measurement of cardiac markers in patients with chest pain: limited value of adding myoglobin to troponin I for exclusion of myocardial infarction. American heart journal, 148(4), 574-581.

Escames, G., Khaldy, H., León, J., González, L., & Acu-a-Castroviejo, D. (2004). Changes in iNOS activity, oxidative stress and melatonin levels in hypertensive patients treated with lacidipine. Journal of hypertension, 22(3), 629-635.

Ferrari, P. F., Palmieri, D., Casazza, A. A., Aliakbarian, B., Perego, P., & Palombo, D. (2015). TNFα-induced endothelial activation is counteracted by polyphenol extract from UV-stressed cyanobacterium Arthrospira platensis. Medicinal Chemistry Research, 24(1), 275-282.

Ferreiro, C. R., Chagas, A. C. P., Carvalho, M. H. C., Dantas, A. P., Jatene, M. B., de Souza, L. C. B., & da Luz, P. L. (2001). Influence of hypoxia on nitric oxide synthase activity and gene expression in children with congenital heart disease: a novel pathophysiological adaptive mechanism. Circulation, 103(18), 2272-2276.

Fukumura, D., Gohongi, T., Kadambi, A., Izumi, Y., Ang, J., Yun, C.-O., . . . Jain, R. K. (2001). Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proceedings of the National Academy of Sciences, 98(5), 2604-2609.
PMid:11226286 PMCid:PMC30185

Funakoshi, H., Kubota, T., Kawamura, N., Machida, Y., Feldman, A. M., Tsutsui, H., . . . Takeshita, A. (2002). Disruption of inducible nitric oxide synthase improves β-adrenergic inotropic responsiveness but not the survival of mice with cytokine-induced cardiomyopathy. Circulation research, 90(9), 959-965.

Funakoshi, H., Kubota, T., Machida, Y., Kawamura, N., Feldman, A. M., Tsutsui, H., . . . Takeshita, A. (2002). Involvement of inducible nitric oxide synthase in cardiac dysfunction with tumor necrosis factor-α. American Journal of Physiology-Heart and Circulatory Physiology, 282(6), H2159-H2166.


Gupta, A., Rhodes, G. J., Berg, D. T., Gerlitz, B., Molitoris, B. A., & Grinnell, B. W. (2007). Activated protein C ameliorates LPS-induced acute kidney injury and downregulates renal INOS and angiotensin 2. American Journal of Physiology-Renal Physiology, 293(1), F245-F254.

Ham, Y.-M., Ko, Y.-J., Song, S.-M., Kim, J., Kim, K.-N., Yun, J.-H., . . . Yoon, W.-J. (2015). Anti-inflammatory effect of litsenolide B2 isolated from Litsea japonica fruit via suppressing NF-κB and MAPK pathways in LPS-induced RAW264. 7 cells. Journal of functional foods, 13, 80-88.

Haywood, G. A., Tsao, P. S., Heiko, E., Mann, M. J., Keeling, P. J., Trindade, P. T., . . . Bishopric, N. H. (1996). Expression of inducible nitric oxide synthase in human heart failure. Circulation, 93(6), 1087-1094.

Heger, J., Gödecke, A., Flögel, U., Merx, M. W., Molojavyi, A., Kühn-Velten, W. N., & Schrader, J. (2002). Cardiac-specific overexpression of inducible nitric oxide synthase does not result in severe cardiac dysfunction. Circulation research, 90(1), 93-99.

Heron, M., & Anderson, R. N. (2016). Changes in the leading cause of death: recent patterns in heart disease and cancer mortality. Cancer, 400(500,000), 600,000.

Heymes, C., Bendall, J. K., Ratajczak, P., Cave, A. C., Samuel, J.-L., Hasenfuss, G., & Shah, A. M. (2003). Increased myocardial NADPH oxidase activity in human heart failure. Journal of the American College of Cardiology, 41(12), 2164-2171.

Ishibashi, M., Hiasa, K.-i., Zhao, Q., Inoue, S., Ohtani, K., Kitamoto, S., . . . Kura, S. (2004). Critical role of monocyte chemoattractant protein-1 receptor CCR2 on monocytes in hypertension-induced vascular inflammation and remodeling. Circulation research, 94(9), 1203-1210.

Islam, M. N., Choi, R. J., Jin, S. E., Kim, Y. S., Ahn, B. R., Zhao, D., . . . Choi, J. S. (2012). Mechanism of anti-inflammatory activity of umbelliferone 6-carboxylic acid isolated from Angelica decursiva. Journal of ethnopharmacology, 144(1), 175-181.

Islam, M. N., Ishita, I. J., Jin, S. E., Choi, R. J., Lee, C. M., Kim, Y. S., . . . Choi, J. S. (2013). Anti-inflammatory activity of edible brown alga Saccharina japonica and its constituents pheophorbide a and pheophytin a in LPS-stimulated RAW 264.7 macrophage cells. Food and Chemical Toxicology, 55, 541-548.

Janakiram, N. B., & Rao, C. V. (2012). iNOS-selective inhibitors for cancer prevention: promise and progress. Future medicinal chemistry, 4(17), 2193-2204.
PMid:23190107 PMCid:PMC3588580

Janssen-Heininger, Y. M., Macara, I., & Mossman, B. T. (1999). Cooperativity between Oxidants and Tumor Necrosis Factor in the Activation of Nuclear Factor (NF)-κ B: Requirement of Ras/Mitogen-Activated Protein Kinases in the Activation of NF-κ B by Oxidants. American journal of respiratory cell and molecular biology, 20(5), 942-952.

Jiang, Q., Elson-Schwab, I., Courtemanche, C., & Ames, B. N. (2000). γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells. Proceedings of the National Academy of Sciences, 97(21), 11494-11499.
PMid:11005841 PMCid:PMC17228

Jin, M., Suh, S.-J., Yang, J. H., Lu, Y., Kim, S. J., Kwon, S., . . . Ahn, G. W. (2010). Anti-inflammatory activity of bark of Dioscorea batatas DECNE through the inhibition of iNOS and COX-2 expressions in RAW264. 7 cells via NF-κB and ERK1/2 inactivation. Food and chemical toxicology, 48(11), 3073-3079.

Jung, H. A., Jin, S. E., Ahn, B. R., Lee, C. M., & Choi, J. S. (2013). Anti-inflammatory activity of edible brown alga Eisenia bicyclis and its constituents fucosterol and phlorotannins in LPS-stimulated RAW264. 7 macrophages. Food and Chemical Toxicology, 59, 199-206.

Kapoor, D., Vijayvergiya, R., & Dhawan, V. (2014). Terminalia arjuna in coronary artery disease: ethnopharmacology, pre-clinical, clinical & safety evaluation. Journal of ethnopharmacology, 155(2), 1029-1045.

Kapur, S., Marcotte, B., & Marette, A. (1999). Mechanism of adipose tissue iNOS induction in endotoxemia. American Journal of Physiology-Endocrinology and Metabolism, 276(4), E635-E641.

Kengatharan, K. M., De Kimpe, S., Robson, C., Foster, S. J., & Thiemermann, C. (1998). Mechanism of gram-positive shock: identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure. Journal of Experimental Medicine, 188(2), 305-315.

Keyes, K. T., Ye, Y., Lin, Y., Zhang, C., Perez-Polo, J. R., Gjorstrup, P., & Birnbaum, Y. (2010). Resolvin E1 protects the rat heart against reperfusion injury. American Journal of Physiology-Heart and Circulatory Physiology, 299(1), H153-H164.

Khan, M. I., Ostadhadi, S., Mumtaz, F., Momeny, M., Moghaddaskho, F., Hassanipour, M., . . . Dehpour, A. R. (2017). Thalidomide attenuates the development and expression of antinociceptive tolerance to μ-opioid agonist morphine through l-arginine-iNOS and nitric oxide pathway. Biomedicine & Pharmacotherapy, 85, 493-502.

Khan, S., & Jena, G. (2014). Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats. Food and chemical toxicology, 73, 127-139.

Khanduja, K. L., Sohi, K. K., Pathak, C. M., & Kaushik, G. (2006). Nimesulide inhibits lipopolysaccharide-induced production of superoxide anions and nitric oxide and iNOS expression in alveolar macrophages. Life sciences, 78(15), 1662-1669.

Kibbe, M. R., Li, J., Nie, S., Watkins, S. C., Lizonova, A., Kovesdi, I., . . . Tzeng, E. (2000). Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate. Journal of vascular surgery, 31(6), 1214-1228.

Korkmaz, B., Buharalioglu, K., Sahan-Firat, S., Cuez, T., Demiryurek, A. T., & Tunctan, B. (2011). Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity in endotoxemic rats. Nitric Oxide, 24(3), 160-172.

Lechner, M., Lirk, P., & Rieder, J. (2005). Inducible nitric oxide synthase (iNOS) in tumor biology: the two sides of the same coin. Paper presented at the Seminars in cancer biology.

Lee, D.-H., Cho, H. J., Kim, J.-T., Choi, J. S., & Joo, C.-K. (2001). Expression of vascular endothelial growth factor and inducible nitric oxide synthase in pterygia. Cornea, 20(7), 738-742.

Lee, H.-H., Paudel, K. R., & Kim, D.-W. (2015). Terminalia chebula fructus inhibits migration and proliferation of vascular smooth muscle cells and production of inflammatory mediators in RAW 264.7. Evidence-Based Complementary and Alternative Medicine, 2015.

Lee, J. K., Sayers, B. C., Chun, K.-S., Lao, H.-C., Shipley-Phillips, J. K., Bonner, J. C., & Langenbach, R. (2012). Multi-walled carbon nanotubes induce COX-2 and iNOS expression via MAP kinase-dependent and-independent mechanisms in mouse RAW264. 7 macrophages. Particle and fibre toxicology, 9(1), 14.
PMid:22571318 PMCid:PMC3485091

Li, X., Ye, X., Li, X., Sun, X., Liang, Q., Tao, L., . . . Chen, J. (2011). Salidroside protects against MPP+-induced apoptosis in PC12 cells by inhibiting the NO pathway. Brain research, 1382, 9-18.

Li, Y., Shen, L., & Luo, H. (2016). Luteolin ameliorates dextran sulfate sodium-induced colitis in mice possibly through activation of the Nrf2 signaling pathway. Int Immunopharmacol, 40, 24-31.

Lim, H.-W., Kumar, H., Kim, B.-W., More, S. V., Kim, I.-W., Park, J.-I., . . . Choi, D.-K. b-Asarone (cis-2, 4, 5-trimethoxy-1-allyl phenyl), attenuates pro-inflammatory mediators by inhibiting NF-jB signaling and the JNK pathway in LPS activated BV-2 microglia cells.

Liu, F.-q., Zhang, X.-l., Gong, L., Wang, X.-p., Wang, J., Hou, X.-g., . . . Zhang, Y. (2011). Glucagon-like peptide 1 protects microvascular endothelial cells by inactivating the PARP-1/iNOS/NO pathway. Molecular and cellular endocrinology, 339(1-2), 25-33.

Liu, X.-m., Peyton, K. J., Wang, X., & Durante, W. (2012). Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways. Biochemical pharmacology, 84(8), 1045-1054.
PMid:22864061 PMCid:PMC3487387

Loh, S. Y., Giribabu, N., & Salleh, N. (2017). Changes in plasma aldosterone and electrolytes levels, kidney epithelial sodium channel (ENaC) and blood pressure in normotensive WKY and hypertensive SHR rats following gonadectomy and chronic testosterone treatment. Steroids.

Lowenstein, C. J., & Padalko, E. (2004). iNOS (NOS2) at a glance. Journal of cell science, 117(14), 2865-2867.

Luoma, J. S., Strålin, P., Marklund, S. L., Hiltunen, T. P., Särkioja, T., & Ylä-Herttuala, S. (1998). Expression of extracellular SOD and iNOS in macrophages and smooth muscle cells in human and rabbit atherosclerotic lesions: colocalization with epitopes characteristic of oxidized LDL and peroxynitrite-modified proteins. Arteriosclerosis, thrombosis, and vascular biology, 18(2), 157-167.

MacMicking, J., Xie, Q.-w., & Nathan, C. (1997). Nitric oxide and macrophage function. Annual review of immunology, 15(1), 323-350.

MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., & Nathan, C. F. (1997). Identification of nitric oxide synthase as a protective locus against tuberculosis. Proceedings of the National Academy of Sciences, 94(10), 5243-5248.

Marumo, T., Nakaki, T., Hishikawa, K., Hirahashi, J., Suzuki, H., Kato, R., & Saruta, T. (1995). Natriuretic peptide-augmented induction of nitric oxide synthase through cyclic guanosine 3', 5'-monophosphate elevation in vascular smooth muscle cells. Endocrinology, 136(5), 2135-2142.

Mayer, B., & Hemmens, B. (1997). Biosynthesis and action of nitric oxide in mammalian cells. Trends in biochemical sciences, 22(12), 477-481.

Metwaly, H., Ebrahem, M. A.-M., & Saku, T. (2014). Vascular endothelial growth factor (VEGF) and inducible nitric oxide synthase (iNOS) in oral lichen planus: An immunohistochemical study for the correlation between vascular and inflammatory reactions. Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology, 26(3), 390-396.

Mogensen, J., Murphy, R. T., Shaw, T., Bahl, A., Redwood, C., Watkins, H., . . . McKenna, W. J. (2004). Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy. Journal of the American College of Cardiology, 44(10), 2033-2040.

Mohib, M. M., Afnan, K., Paran, T. Z., Khan, S., Sarker, J., Hasan, N., . . . Sagor, M. A. T. (2017). Beneficial Role of Citrus Fruit Polyphenols Against Hepatic Dysfunctions: A Review. Journal of dietary supplements, 1-29.

Mohib, M. M., Hasan, I., Chowdhury, W. K., Chowdhury, N. U., Mohiuddin, S., Sagor, M. A. T., . . . Alam, M. A. (2016). Role of angiotensin ii in hepatic inflammation through MAPK pathway: A review. Hepatitis.

Mohib, M. M., Rabby, S. F., Paran, T. Z., Hasan, M. M., Ahmed, I., Hasan, N., . . . Mohiuddin, S. (2016). Protective role of green tea on diabetic nephropathy—A review. Cogent Biology, 2(1), 1248166.

Mohib, M. M., Rabby, S. M. F., Paran, T. Z., Hasan, M. M., Ahmed, I., Hasan, N., . . . Hsu, T.-C. (2016). Protective role of green tea on diabetic nephropathy -A review. Cogent Biology, 1248166. doi:10.1080/23312025.2016.1248166

Müller-Werdan, U., Schumann, H., Fuchs, R., Reithmann, C., Loppnow, H., Koch, S., . . . Jungblut, P. (1997). Tumor Necrosis Factorα (TNFα) is Cardiodepressant in Pathophysiologically Relevant Concentrations Without Inducing Inducible Nitric Oxide-(NO)-Synthase (iNOS) or Triggering Serious Cytotoxicity. Journal of molecular and cellular cardiology, 29(11), 2915-2923.

Mungrue, I. N., Gros, R., You, X., Pirani, A., Azad, A., Csont, T., . . . Husain, M. (2002a). Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. The Journal of clinical investigation, 109(6), 735-743.
PMid:11901182 PMCid:PMC150906


Mungrue, I. N., Gros, R., You, X., Pirani, A., Azad, A., Csont, T., . . . Husain, M. (2002b). Cardiomyocyte overexpression of iNOS in mice results in peroxynitrite generation, heart block, and sudden death. The Journal of clinical investigation, 109(6), 735.
PMid:11901182 PMCid:PMC150906

Nathan, C. (1992). Nitric oxide as a secretory product of mammalian cells. The FASEB journal, 6(12), 3051-3064.

Padureanu, V., Enescu, A. S., Silosi, I., Fortofoiu, M., Enescu, A., Bogdan, M., . . . Mita, A. (2017). The association between chronic pancreatitis and the iNOS-2087A> G polymorphism. Romanian Journal of Internal Medicine, 55(2), 89-95.

Palmer, J., Guillard, F., Laurijssens, B., Wentz, A., Dixon, R., & Williams, P. (2009). A randomised, single-blind, placebo-controlled, adaptive clinical trial of GW274150, a selective iNOS inhibitor, in the treatment of acute migraine. Cephalalgia, 29(1), 124.

Papapetropoulos, A., García-Carde-a, G., Madri, J. A., & Sessa, W. C. (1997). Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. The Journal of clinical investigation, 100(12), 3131-3139.
PMid:9399960 PMCid:PMC508526

Piplani, H., Vaish, V., & Sanyal, S. N. (2012). Dolastatin 15, a mollusk linear peptide, and Celecoxib, a selective cyclooxygenase-2 inhibitor, prevent preneoplastic colonic lesions and induce apoptosis through inhibition of the regulatory transcription factor NF-κB and an inflammatory protein, iNOS. European Journal of Cancer Prevention, 21(6), 511-522.

Ramlagan, P., Rondeau, P., Planesse, C., Neergheen-Bhujun, V. S., Fawdar, S., Bourdon, E., & Bahorun, T. (2017). Punica granatum L. mesocarp suppresses advanced glycation end products (AGEs)-and H 2 O 2-induced oxidative stress and pro-inflammatory biomarkers. Journal of Functional Foods, 29, 115-126.

Rasoanaivo, P., Wright, C. W., Willcox, M. L., & Gilbert, B. (2011). Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria Journal, 10(1), S4.
PMid:21411015 PMCid:PMC3059462

Rodrigues, J. P. F., Caldas, I. S., Gonçalves, R. V., Almeida, L. A., Souza, R. L. M., & Novaes, R. D. (2017). S. mansoni-T. cruzi co-infection modulates arginase-1/iNOS expression, liver and heart disease in mice. Nitric Oxide, 66, 43-52.

Romano, B., Pagano, E., Orlando, P., Capasso, R., Cascio, M. G., Pertwee, R., . . . Borrelli, F. (2016). Pure Δ 9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ 9-tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages. Pharmacological Research, 113, 199-208.

Ryu, S., Shin, J.-S., Cho, Y.-W., Kim, H. K., Paik, S. H., Lee, J. H., . . . Lee, K.-T. (2013). Fimasartan, anti-hypertension drug, suppressed inducible nitric oxide synthase expressions via nuclear factor-kappa B and activator protein-1 inactivation. Biological and Pharmaceutical Bulletin, 36(3), 467-474.

Sagor, M. A. T., Mohib, M., Tabassum, N., Ahmed, I., & Reza, H. (2016). Fresh seed supplementation of Syzygium cumini attenuated oxidative stress, inflammation, fibrosis, iron overload, hepatic dysfunction and renal injury in acetaminophen induced rats. Journal of Drug Metabolism & Toxicology, 7(2).

Sagor, M. A. T., Tabassum, N., Potol, M. A., & Alam, M. A. (2015). Xanthine oxidase inhibitor, allopurinol, prevented oxidative stress, fibrosis, and myocardial damage in isoproterenol induced aged rats. Oxidative medicine and cellular longevity, 2015.
PMid:26137187 PMCid:PMC4475550

Sagor, M. A. T., Tabassum, N., Potol, M. A., & Alam, M. A. (2015). Xanthine Oxidase Inhibitor, Allopurinol, Prevented Oxidative Stress, Fibrosis, and Myocardial Damage in Isoproterenol Induced Aged Rats. Oxidative Medicine and Cellular Longevity, 2015, 9. doi:10.1155/2015/478039

Salerno, J. C., Harris, D. E., Irizarry, K., Patel, B., Morales, A. J., Smith, S. M., . . . Jones, C. L. (1997). An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. Journal of Biological Chemistry, 272(47), 29769-29777.

Salvemini, D., Nucci, G., Sneddon, J. M., & Vane, J. R. (1989). Superoxide anions enhance platelet adhesion and aggregation. British journal of pharmacology, 97(4), 1145-1150.
PMid:2551440 PMCid:PMC1854596

Sangartit, W., Pakdeechote, P., Kukongviriyapan, V., Donpunha, W., Shibahara, S., & Kukongviriyapan, U. (2016). Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice. Vascular Pharmacology, 87, 199-208.

Sarady, J. K., Zuckerbraun, B. S., Bilban, M., Wagner, O., Usheva, A., Liu, F., . . . Otterbein, L. E. (2004). Carbon monoxide protection against endotoxic shock involves reciprocal effects on iNOS in the lung and liver. The FASEB journal, 18(7), 854-856.

Satoh, M., Nakamura, M., Tamura, G., Makita, S., Segawa, I., Tashiro, A., . . . Hiramori, K. (1997). Inducible nitric oxide synthase and tumor necrosis factor-alpha in myocardium in human dilated cardiomyopathy. Journal of the American College of Cardiology, 29(4), 716-724.

Seccombe, J. F., Pearson, P. J., & Schaff, H. V. (1994). Oxygen radical—mediated vascular injury selectively inhibits receptor-dependent release of nitric oxide from canine coronary arteries. The Journal of thoracic and cardiovascular surgery, 107(2), 505-509.

Seo, S., Shin, J.-S., Lee, W.-S., Rhee, Y. K., Cho, C.-W., Hong, H.-D., & Lee, K.-T. (2017). Anti-colitis effect of Lactobacillus sakei K040706 via suppression of inflammatory responses in the dextran sulfate sodium-induced colitis mice model. Journal of Functional Foods, 29, 256-268.

Shabeeh, H., Khan, S., Jiang, B., Brett, S., Melikian, N., Casadei, B., . . . Shah, A. M. (2017). Blood Pressure in Healthy Humans Is Regulated by Neuronal NO SynthaseNovelty and Significance. Hypertension, 69(5), 970-976.
PMid:28264923 PMCid:PMC5389591

Shimabukuro, M., Ohneda, M., Lee, Y., & Unger, R. H. (1997). Role of nitric oxide in obesity-induced beta cell disease. Journal of Clinical Investigation, 100(2), 290.
PMid:9218505 PMCid:PMC508191

Simsekyilmaz, S., Cabrera-Fuentes, H. A., Meiler, S., Kostin, S., Baumer, Y., Liehn, E. A., . . . Zernecke, A. (2013). The role of extracellular RNA in atherosclerotic plaque formation in mice. Circulation, CIRCULATIONAHA. 113.002562.

Sun, Y., Carretero, O. A., Xu, J., Rhaleb, N.-E., Wang, F., Lin, C., . . . Yang, X.-P. (2005). Lack of inducible NO synthase reduces oxidative stress and enhances cardiac response to isoproterenol in mice with deoxycorticosterone acetate–salt hypertension. Hypertension, 46(6), 1355-1361.
PMid:16286571 PMCid:PMC4601605

Taylor, B. S., & Geller, D. A. (2000). Molecular regulation of the human inducible nitric oxide synthase (iNOS) gene. Shock (Augusta, Ga.), 13(6), 413-424.

Tikellis, C., Thomas, M. C., Harcourt, B. E., Coughlan, M. T., Pete, J., Bialkowski, K., . . . Forbes, J. M. (2008). Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs. American Journal of Physiology-Endocrinology and Metabolism, 295(2), E323-E330.
PMid:18477705 PMCid:PMC2652498

Vannini, F., Kashfi, K., & Nath, N. (2015). The dual role of iNOS in cancer. Redox biology, 6, 334-343.
PMid:26335399 PMCid:PMC4565017

Vejlstrup, N. G., Bouloumie, A., Boesgaard, S., Andersen, C. B., Nielsen-Kudsk, J. E., Mortensen, S. A., . . . Aldershvile, J. (1998). Inducible nitric oxide synthase (iNOS) in the human heart: expression and localization in congestive heart failure. Journal of molecular and cellular cardiology, 30(6), 1215-1223.

Wang, W. Z., Fang, X. H., Stepheson, L. L., Khiabani, K. T., & Zamboni, W. A. (2004). NOS upregulation attenuates vascular endothelial dysfunction in the late phase of ischemic preconditioning in skeletal muscle. Journal of orthopaedic research, 22(3), 578-585.

Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., . . . Riad, A. (2010). Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circulation: Heart Failure, CIRCHEARTFAILURE. 109.931451.

Wever, R. M., Lüscher, T. F., Cosentino, F., & Rabelink, T. J. (1998). Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation, 97(1), 108-112.

Wong, M.-L., Rettori, V., Amer, A.-S., Bongiorno, P. B., Canteros, G., McCann, S. M., . . . Licinio, J. (1996). Inducible nitric oxide synthase gene expression in the brain during systemic inflammation. Nature medicine, 2(5), 581-584.

Xia, M., Ling, W. H., Ma, J., Kitts, D. D., & Zawistowski, J. (2003). Supplementation of diets with the black rice pigment fraction attenuates atherosclerotic plaque formation in apolipoprotein e deficient mice. The Journal of nutrition, 133(3), 744-751.

Xia, X., Ling, W., Ma, J., Xia, M., Hou, M., Wang, Q., . . . Tang, Z. (2006). An anthocyanin-rich extract from black rice enhances atherosclerotic plaque stabilization in apolipoprotein E–deficient mice. The Journal of nutrition, 136(8), 2220-2225.

Xu, W., Charles, I. G., Moncada, S., Gorman, P., Sheer, D., Liu, L., & Emson, P. (1994). Mapping of the genes encoding human inducible and endothelial nitric oxide synthase (NOS2 and NOS3) to the pericentric region of chromosome 17 and to chromosome 7, respectively. Genomics, 21(2), 419-422.

Xuan, Y.-T., Guo, Y., Han, H., Zhu, Y., & Bolli, R. (2001). An essential role of the JAK-STAT pathway in ischemic preconditioning. Proceedings of the National Academy of Sciences, 98(16), 9050-9055.
PMid:11481471 PMCid:PMC55371

Yang, B., Larson, D. F., & Watson, R. R. (2004). Modulation of iNOS activity in age-related cardiac dysfunction. Life sciences, 75(6), 655-667.

Ying, L., & Hofseth, L. J. (2007). An emerging role for endothelial nitric oxide synthase in chronic inflammation and cancer. Cancer Research, 67(4), 1407-1410.

Yoda, Y., Amagase, K., Kato, S., Tokioka, S., Murano, M., Kakimoto, K., . . . Higuchi, K. (2010). Prevention by lansoprazole, a proton pump inhibitor, of indomethacin-induced small intestinal ulceration in rats through induction of heme oxygenase-1. Journal of Physiology and Pharmacology, 61(3), 287.

Yu, G., Cheng, M., Wang, W., Zhao, R., & Liu, Z. (2017). Involvement of WNK1-mediated potassium channels in the sexual dimorphism of blood pressure. Biochemical and Biophysical Research Communications, 485(2), 255-260.

Yu, X. W., Chen, Q., Kennedy, R. H., & Liu, S. J. (2005). Inhibition of sarcoplasmic reticular function by chronic interleukin-6 exposure via iNOS in adult ventricular myocytes. The Journal of physiology, 566(2), 327-340.

Zhang, J., Peng, B., & Chen, X. (2005). Expressions of nuclear factor κB, inducible nitric oxide synthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary glands: correlations with the angiogenesis and clinical outcome. Clinical Cancer Research, 11(20), 7334-

Committee on Publication Ethics

Full Text
Export Citation

View Dimensions

View Plumx

View Altmetric